Crowdonomics
All companies

THC Farmaceuticals, Inc.

Operating

Fintech · Scottsdale, AZ

Estimated pre-money ⓘ
$9.1M
As of Feb 2023 · from Reg CF Offering (2023) · our estimate: offering price × shares outstanding, not a stated valuation
Total raised
$0
Across 1 round since 2023
Latest share price
$0.50
Reg CF Offering (2023) offering price

Financials

FY2010–FY2025 (no data for FY2015, FY2016, FY2017, FY2018, FY2019) · from SEC filings · hover any figure for its source
$22K
−$24K
2013
$19K
−$31K
2014
2015no data
2016no data
2017no data
2018no data
2019no data
$2K
−$17K
2020
2021
$10K
$17K
2022
$0
$15K
2023
$0
−$2K
2024
$0
−$10K
2025
RevenueNet income — beside revenue when positive, below the line when a loss

Chart shows the most recent 8 fiscal years; 3 earlier years are in the table below.

Metric
FY2010 audited
FY2011 audited
FY2012 audited
FY2013 audited
FY2014 audited
FY2020 unaudited*
FY2021 unaudited*
FY2022
FY2023
FY2024
FY2025
Income statement
Revenue
—
$34,159
$30,579
$21,640
$19,034
$2,234
—
$10,000
$0
$0
$0
Cost of goods sold
—
—
—
—
—
$0
—
$0
$0
$0
$0
Gross margin
—
—
—
—
—
100%
—
100%
—
—
—
Net income
—
-$28,360
-$39,692
-$23,837
-$30,697
-$16,806
—
$16,806
$14,976
-$2,476
-$10,396
Taxes paid
—
—
$0
$0
$0
$0
—
$0
$0
$0
$0
Balance sheet
Cash
$6,551
$4,123
$2,309
$579
$637
$18,839
—
$1,714
$1,714
$1,714
$0
Accounts receivable
$3,527
$2,146
$2,028
$1,741
$1,754
$11,350
—
$11,350
$11,350
$11,350
$0
Total assets
$116,087
$65,813
$51,745
$48,679
$48,150
$2,795,793
—
$2,776,287
$2,745,097
$2,740,145
$2,718,777
Short-term debt
—
—
—
—
—
$587,662
—
$142,095
$142,095
$26,826
$26,249
Long-term debt
—
—
—
—
—
$0
—
$0
$0
$115,269
$115,269
Total liabilities
$41,516
$19,602
$45,226
$65,997
$96,165
$587,662
—
$142,095
$142,095
$142,095
$141,518
Other
Headcount
—
—
—
—
—
—
2
—
2
2
1

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Valuation over rounds

Pre-money — the valuation set before each round’s money came in
$9.1M
est. pre-money
Reg CF · Common · Feb 2023

Dotted grey bars are our estimate for rounds that didn't state one: the round's share price × the shares outstanding in its filings. Same measure as blue, but rougher.

Cap table

Share counts as of Dec 31, 2025
Preferred Stock · 7.64%Common Stock · 92.4%
ClassOutstandingVotes / shareShare of totalLast price
Preferred Stockpreferred1,500,000—7.64%—
Common Stock18,131,600—92.4%—
Total19,631,600100%

Shares outstanding over timein today's share terms

1.7B855M0
Jun 2011Dec 2025
Common StockPreferred Stock

Changes in named holdersshares in today's terms · % of all shares at the time

Principal holders% as the filing states it, May 11, 2026

  • Weed Growth Fund, Inc.58.0%of company
  • David Tobias15.5%of company
  • Everyone else (not named in filings)26.5%

From the company's SEC filings: share counts per class, each class's voting and conversion terms, and the holders of 20% or more that Form C requires (officers and 10%+ holders on Form 1-A). Filings name only large holders, so most owners — including crowd investors — are not listed, and a holder's percentage may be of its own class rather than of the whole company. Prices and crowd share counts are in today's share terms — adjusted for splits and conversions since they were sold. Hover a figure for its filing.

Fundraising history

Reg CF · Common Stock · Feb 2023Closedvia ChainRaise Portal LLC
Raised $0 / $124KEst. pre-money $9.1M

Team

1 person
/s/David Tobias
Chairman of the Board of Directors, and Chief Operating Officer

Names and titles as disclosed on SEC Form C. Bios and photos come from the platform campaign page and may be out of date.

Reg CF annual-report compliance

Not obligated

never closed a Reg CF raise

Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.

  • Form C-AR/AMay 11, 20260001508594-26-000006
    EDGAR
  • Form C-ARApr 30, 20260001508594-26-000005
    EDGAR
  • Form C-ARJan 27, 20260001508594-26-000002
    EDGAR
  • Form C-ARJan 24, 20250001508594-25-000001
    EDGAR
  • Form C-AR/AJun 25, 20240001508594-24-000004
    EDGAR
  • Form C-ARFeb 7, 20240001508594-24-000001
    EDGAR
  • Form C/ASep 12, 20230001508594-23-000004
    EDGAR
  • Form C/AMar 23, 20230001508594-23-000003
    EDGAR
Source: SEC EDGARCIK 0001508594UTShare price $0.50Last synced Aug 17, 2026

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.